Compare Topics
Select two topics to compare story counts, sentiment, impact scores, and recent headlines.
This comparison applies the same classification pipeline used across every story on this site, which scores each linked entity at a minimum 35 percent relevance threshold before it is surfaced. According to our editorial methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.
Compare any two topics
Choose Topic A and Topic B from the dropdowns above to see a side-by-side analysis of story volume, sentiment, and recent headlines.
Coverage by topic
Every figure below counts the full Biotech Intelligence Brief record for that topic, not a sample. Impact is our 0-10 editorial score; see the methodology for how topics are assigned and impact is derived.
| Topic | Stories | Share | Avg impact | Latest |
|---|---|---|---|---|
| Pharma | 523 | 64.7% | 5.9 | 2026-09-12 |
| Clinical Trials | 104 | 12.9% | 6.5 | 2026-09-10 |
| FDA Actions | 73 | 9% | 6.6 | 2026-09-09 |
| Funding | 60 | 7.4% | 6 | 2026-09-11 |
| Acquisitions | 21 | 2.6% | 6.7 | 2026-09-07 |
| Gene & Cell Therapy | 20 | 2.5% | 6.2 | 2026-09-09 |
| IPOs & Funding | 7 | 0.9% | 5.6 | 2026-03-24 |